Abstract

Research Article

Rehabilitation of hearing by cochlear implantation

Abdelaziz Raji*, Houda Mounji, Youssef Rochdi, Hassan Nouri and Mehdi Elfakiri

Published: 24 July, 2019 | Volume 3 - Issue 2 | Pages: 082-086

Background: Cochlear implants (CI) are nowadays a widely accepted treatment for sensorineural hearing loss SNHL.

Aim: This study aimed to describe the epidemiological characteristics and the surgical approach and to evaluate the outcomes of our experience in cochlear implantation.

Setting: Department of Otolaryngology-Head and Neck Surgery of University Hospital Mohammed VI Marrakech Morocco.

Methods: A retrospective chart review was conducted on 113 patients with severe to profound hearing loss who underwent a cochlear implantation between 2007-2018.

Results: There were 65 females and 48 males with severe to profound bilateral deafness, of whom 103 had prelingual deafness. The mean age of pediatric cochlear implantation was 5.25 years. Implantation was unilateral in all patients. The procedure was followed by regular adjustments and speech therapy. The evaluation was carried out by the same team each month during the first 6 months, then every 6 months. The average duration of follow-up was 37.54 months. All patients benefited from their implants with inter individual variability.

The good results were correlated with early implantation, significant parental investment and a steady follow-up of speech therapy.

Conclusion: Cochlear implantation has revolutionized the management of severe to profound deafness. It is a safe and effective technique when it is aimed at correctly selected populations.

Read Full Article HTML DOI: 10.29328/journal.jnpr.1001028 Cite this Article Read Full Article PDF

Keywords:

Hearing loss; Cochlear implant; Rehabilitation; Speech

References

  1. Nicholas L, Deep Eric M, Jethanamest D, Matthew L. Carlson: Cochlear Implantation: An Overview. J Neurol Surg B Skull Base. 2019; 80: 169-177. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30931225
  2. Centers for Disease Control and Prevention. National Center on Birth Defects and Developmental Disabilities. Hearing loss. 1999.
  3. Vincenzo V, Bacciu A, Guida M, Marra F, Bertoldi B, et al. Pediatric cochlear implantation: an update. Ital J Pediatr. 2014; 40: 72. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25179127
  4. Tajudeen BA, Waltzman SB, Jethanamest D, Svirsky MA. Speech perception in congenitally deaf children receiving cochlear implants in the first year of life. Otol Neurotol. 2010; 31: 1254–1260. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20814343
  5. Holman MA, Carlson ML, Driscoll CL, Grim KJ, Petersson RS, et al. Cochlear implantation in children 12 months of age and younger. Otol Neurotol. 2013; 34: 251–258. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23444471
  6. Colletti L, Mandalà M, Colletti V. Cochlear implants in children younger than 6 months. Otolaryngol Head Neck Surg. 2012; 147: 139–146. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22454156
  7. Tucci DL, Telian SA, Zimmerman-Phillips S, Zwolan TA, Kileny PR. Cochlear implantation in patients with cochlear malformations. Arch Otolaryngol Head Neck Surg. 1995; 121: 833–838.
  8. Mondain M, Sillon M, Vieu A, Levi A, Reuillard-Artieres F, et al. Cochlear implantation in prelingually deafened children with residual hearing. Int J Pediatr Otorhinolaryngol. 2002; 63: 91–97. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11955600
  9. Dowell RC, Hollow R, Winton E. Outcomes for cochlear implant users with significant residual hearing. Arch Otolaryngol Head Neck Surg. 2004; 130: 575–581. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15148179
  10. Hansen MR, GantzBJ, DunnC. Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Ménière’s disease. Otol Neurotol. 2013; 34: 1681–1687. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24232066
  11. Parry DA, Booth T, Roland PS. Advantages of magnetic resonance imaging over computed tomography in preoperative evaluation of pediatric cochlear implant candidates. Otol Neurotol. 2005; 26: 976–982. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16151346
  12. Ellul S, Shelton C, Davidson HC, Harnsberger HR. Preoperative cochlear implant imaging: is magnetic resonance imaging enough? Am J Otol. 2000; 21: 528-533.
  13. Shabashev S, Fouad Y, Huncke TK, Roland JT. Cochlear implantation under conscious sedation with local anesthesia; safety, efficacy, costs, and satisfaction. Cochlear Implants Int. 2017; 18: 297–303. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28934019
  14. Reefhuis J, Honein MA, Whitney CG, Chamany S, Mann EA, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003; 349: 435-445. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12890842
  15. Heman-Ackah SE, Roland JT Jr, Haynes DS, Waltzman SB. Pediatric cochlear implantation: candidacy evaluation, medical and surgical considerations and expanding criteria. Otolaryngol Clin N Am. 2012; 45: 41–67. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22115681
  16. O’Donoghue GM, Nikolopoulos TP, Archbold SM, Tait M. Speech perception in children after cochlear implantation. Am J Otol. 1998; 19: 762-767. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9831151
  17. Allen MC, Nikolopoulos TP, O’Donoghue GM. Speech intelligibility in children after cochlear implantation. Am J Otol. 1998; 19: 742-746.
  18. Gérard JM, Deggouj N, Hupin C, Buisson AL, Monteyne V, et al. Evolution of communication abilities after cochlear implantation in prelingually deaf children. Int J Pediatr Otorhinolaryngol. 2010; 74: 642-648. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20347162
  19. Clark JH, Aggarwal P, Wang NY, Robinson R, Niparko JK, et al. Measuring communicative performance with the FAPCI instrument: preliminary results from normal hearing and cochlear implanted children. Int J Pediatr Otorhinolaryngol. 2011; 75: 549-553. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21296432

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Similar Articles

Recently Viewed

  • Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC
    Tobias R Overbeck*, Stefan HP Wenleder*, Bernhard C Danner, Wolfgang Körber, Karin Toepelt, Bernhard Hemmerlein, Christina Perske, Markus Falk, Markus Tiemann, Claudia Tomala, Elke Stitz and Frank Griesinger Tobias R Overbeck*,Stefan HP Wenleder*,Bernhard C Danner,Wolfgang Körber, Karin Toepelt,Bernhard Hemmerlein, Christina Perske,Markus Falk,Markus Tiemann,Claudia Tomala,Elke Stitz,Frank Griesinger. Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC. J Pulmonol Respir Res. 2021: doi: 10.29328/journal.jprr.1001018; 5: 001-018
  • Seasonal change and COVID-19: Will the harmattan season lead to an increase in COVID-19 cases in Nigeria?
    Prince Chiagozie Ekoh* Prince Chiagozie Ekoh*. Seasonal change and COVID-19: Will the harmattan season lead to an increase in COVID-19 cases in Nigeria?. J Pulmonol Respir Res. 2020: doi: 10.29328/journal.jprr.1001017; 4: 021-022
  • Mestranol moieties clicked to Zn(II)phthalocyanine for controllable photosensitized oxidation of cholesterol
    Vanya Mantareva*, Meliha Syuleyman, Adriana Slavova-Kazakova, Ivan Angelov and Mahmut Durmus Vanya Mantareva*,Meliha Syuleyman,Adriana Slavova-Kazakova,Ivan Angelov,Mahmut Durmus. Mestranol moieties clicked to Zn(II)phthalocyanine for controllable photosensitized oxidation of cholesterol. Arch Biotechnol Biomed. 2021: doi: 10.29328/journal.abb.1001027; 5: 041-048
  • Spontaneous pneumomediastinum associated with COVID-19: Rare complication of 2020 pandemic
    Arnaldo A Nieves-Ortiz*, Vanessa Fonseca-Ferrer, Kyomara Hernández-Moya, Keren Mendez Ramirez, Jose Ayala-Rivera, Marangely Delgado, Juan Garcia-Puebla, Rosangela Fernández-Medero and Ricardo Fernandez-Gonzalez Arnaldo A Nieves-Ortiz*,Vanessa Fonseca-Ferrer, Kyomara Hernández-Moya,Keren Mendez Ramirez,Jose Ayala-Rivera,Marangely Delgado, Juan Garcia-Puebla,Rosangela Fernández-Medero,Ricardo Fernandez-Gonzalez. Spontaneous pneumomediastinum associated with COVID-19: Rare complication of 2020 pandemic. J Pulmonol Respir Res. 2020: doi: 10.29328/journal.jprr.1001016; 4: 018-020
  • General practitioners’ knowledge, attitudes and practices on antibiotic prescribing for acute respiratory infections in children in Lubumbashi, Democratic Republic of Congo
    Aubin Ndjadi Wembonyama Kasongo, Olivier Mukuku*, Gray A-Wakamb Kanteng, Mick Ya-Pongombo Shongo, André Kabamba Mutombo, Albert Mwembo-A-Nkoy Tambwe, Dieudonné Tshikwej Ngwej, Stanis Okitotsho Wembonyama and Oscar Numbi Luboya Aubin Ndjadi Wembonyama Kasongo,Olivier Mukuku*,Gray A-Wakamb Kanteng,Mick Ya-Pongombo Shongo,André Kabamba Mutombo,Albert Mwembo-A-Nkoy Tambwe,Dieudonné Tshikwej Ngwej,Stanis Okitotsho Wembonyama,Oscar Numbi Luboya. General practitioners’ knowledge, attitudes and practices on antibiotic prescribing for acute respiratory infections in children in Lubumbashi, Democratic Republic of Congo. J Pulmonol Respir Res. 2020: doi: 10.29328/journal.jprr.1001015; 4: 011-017

Read More

Most Viewed

Read More

Help ?